Cardiovascular risk assessment in persons with HIV infection in the developing world: Comparing three risk equations in a cohort of HIV-infected Thais

HIV Medicine

Volumn 12, Issue 8, 2011, Pages 510-515

  Edwards Jackson, N ^a   Kerr, S J ^b,c   Tieu, H V ^a,d   Ananworanich, J ^b,e,f   Hammer, S M ^a   Ruxrungtham, K ^b,f   Phanuphak, P ^b,f   Avihingsanon, Anchalee ^b,f  

^a Columbia University College of Physicians Surgeons ^*  (United States)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NEW YORK BLOOD CENTER   (United States)

^e South East Asia Research Collaboration with Hawaii ^*  (Thailand)

^f CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Coronary artery disease; Developing countries; HIV; Risk assessment; Thailand

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY RISK; DEVELOPING COUNTRY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; THAILAND;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUSTRALIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; THAILAND;

EID: 80051597585     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00916.x     Document Type: Article

References (13)

1. Law MG, Friis-Møller N, Weber R et al. Modelling the 3-year risk of myocardial infarction among participants in the data collection on adverse events of anti-HIV drugs (D:A:D) study. HIV Med 2003; 4: 1-10.
2. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
3. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral therapy. N Engl J Med 2006; 355: 2283-2296.
4. Bergersen BM, Sandvik L, Bruun JN, Tonstad S. Elevated Framingham risk score in HIV-positive patients of highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol 2004; 23: 625-630.
5. Mondy K, Overton ET, Grubb J et al. Metabolic syndrome in HIV-infected patients from an urban, Midwestern U.S. outpatient population. Clin Infect Dis 2007; 44: 726-734.
6. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med 2004; 350: 2438-2440.
7. Sritara P, Cheepudomwit S, Chapman N et al. Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3, 499 Thais: the Electricity Generating Authority of Thailand study. Int J Epidemiol 2003; 32: 461-468.
8. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
9. Asia Pacific Cohort Studies Collaboration. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Commun Health 2007; 61: 115-121.
10. Yamwong S. Final report. The development of coronary heart disease assessment [technical report on the Internet]. Bangkok (Thailand): National Health Foundation (ThaiNHF); 2005 December. Available at using login name and password. Thai (accessed 9 October 2009).
11. Friis-Møller N, Thiébaut R, Reiss P et al. Predicting the risk of cardiovascular disease in HIV-infected patients; the data-collection on adverse effects of anti-HIV drugs (D:A:D) study. Eur J Cardiovasc Prev Rehabil 2010; 17: 491-501.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310.